News | December 02, 2021
Molnupiravir, a step closer to approval in the fight against Covid-19
The U.S. FDA advisory committee voted 13-10 in favour of the oral antiviral medicine
The U.S. FDA advisory committee voted 13-10 in favour of the oral antiviral medicine
Researchers observed that the Pfizer/BioNTech and Moderna vaccines were 78% and 73% effective in preventing Covid-19 infections, respectively
Booster dose is available to all residents aged 18+ and can be applied six months after the second dose of any other vaccine administered in UAE
Merck has shared these additional analyses with the FDA and they will be presented to the FDA’s Antimicrobial Drugs Advisory Committee on Nov. 30th
One-shot Sputnik Light is a highly effective vaccine when used both on standalone basis and applied as a booster
A first for the Asian market, addressing the health spends needs of over 200 million households.
This is a shot in the arm for the vaccine manufacturers
If approved or authorized, Paxlovid would be the first oral antiviral of its kind, to combat SARS-CoV-2
The start-up has announced the scheme to mark World Diabetes Day
The Drug Controller General of India (DCGI), is reviewing clinical data of molnupiravir for the treatment of Covid-19 in adults in India
Subscribe To Our Newsletter & Stay Updated
